Delivering Localized Trial Access.
EmVenio Research delivers localized trial access to diverse and underserved communities.
We empower patients and embrace communities on their terms. Our research solutions cultivate a sustainable local ecosystem that benefits all stakeholders. Removing barriers and unlocking doors to innovation reduces risk and time associated with clinical research, while improving ROI.
EmVenio Research, now a PCM Trials company, is the largest independent DCT site network and the most experienced provider of local clinical trial access globally. Combined market leadership in mobile visits and Community Research Sites allows us to significantly improve participants’ overall experience in clinical trials.
Global Network.
Mobile Solutions.
Local Access.
45+ Community Research Sites Activated
190+ EmVenio Mobile Clinicians Deployed
It all starts local.
Local Communities
Local Clinical Trial Access
Local Staff
Local to YOU
Empowering Peformance
%
Of EmVenio’s trial participants from minority populations, compared to a less than 20% industry average.
%
Retention rate for EmVenio trial participants, compared to a 70% industry average.
%
Of 2,500 patients in a recent study were from underserved populations.
Explore Our Latest Blogs & News
EmVenio’s clinical research sites at Prime Healthcare hospitals now open in Dallas and Atlanta
Pre-study visits now available for clinical research organizations and trial sponsors DURHAM, N.C., Aug. 1, 2024 /PRNewswire/ -- EmVenio Research announced today it has opened two dedicated research centers within the Prime Healthcare hospital...
Prime Healthcare prepares to open clinical trial research center at KC-area hospital
Source Kansas City Business Journal...
The FDA’s timeline: advancing diversity in clinical trials
The United States Food and Drug Administration...